Do statins prevent acute kidney injury?

Bibliography

• Antoniou GA, Hajibandeh S, Hajibandeh S, et al. Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery. J Vasc Surg 2014;61(2):519-32e1
   PubMed Web of Science ®Google Scholar
• Mehrbod P, Omar AR, Hair-Bejo M, et al. Mechanisms of Action and Efficacy of Statins against Influenza. BioMed Res Int 2014;2014:872370
   PubMed Web of Science ®Google Scholar
• de Mones E, Schlaubitz S, Catros S, Fricain JC. Statins and alveolar bone resorption: a narrative review of preclinical and clinical studies. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119(1):65-73
   Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Agusti A. Statins as adjunct therapy in COPD: how do we cope after STATCOPE? Thorax 2014;69(10):891-4
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Short PM, Mandal P, et al. Statins in community acquired pneumonia: Evidence from experimental and clinical studies. Respir Med 2010;104(8):1081-91
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008;121(11):1002-7
   PubMed Web of Science ®Google Scholar
• Chou CY, Chou YC, Chou YJ, et al. Statin use and incident dementia: a nationwide cohort study of Taiwan. Int J Cardiol 2014;173(2):305-10
   PubMed Web of Science ®Google Scholar
• Janda S, Young A, FitzGerald JM, et al. The effect of statins on mortality from severe infections and sepsis: A systematic review and meta-analysis. J Critical Care 2010;25(4):656e7-56e22
   Google Scholar
• Kouroumichakis I, Papanas N, Proikaki S, et al. Statins in prevention and treatment of severe sepsis and septic shock. Eur J Intern Med 2011;22(2):125-33
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ 2010;340:c2197
   PubMed Web of Science ®Google Scholar
• Dormuth CR, Hemmelgarn BR, Paterson JM, et al. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ 2013;346:f880
   PubMed Web of Science ®Google Scholar
• Layton JB, Brookhart MA, Jonsson Funk M, et al. Acute kidney injury in statin initiators. Pharmacoepidemiol Drug Saf 2013;22(10):1061-70
   PubMed Web of Science ®Google Scholar
• Corrao G, Soranna D, Casula M, et al. High-potency statins increase the risk of acute kidney injury: Evidence from a large population-based study. Atherosclerosis 2014;234(1):224-9
   PubMed Web of Science ®Google Scholar
• Chung YH, Lee YC, Chang CH, et al. Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure. Pharmacoepidemiol Drug Saf 2013;22(6):583-92
   PubMed Web of Science ®Google Scholar
• Sakaeda T, Kadoyama K, Okuno Y. Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system. PLoS One 2011;6(12):e28124
   PubMed Web of Science ®Google Scholar
• Murugan R, Kellum JA. Acute kidney injury: what’s the prognosis? Nat Rev Nephrol 2011;7(4):209-17
   PubMed Web of Science ®Google Scholar
• Waikar SS, Wald R, Chertow GM, et al. Validity of international classification of diseases, ninth revision, clinical modification codes for acute renal failure. J Am Soc Nephrol 2006;17(6):1688-94
   PubMed Web of Science ®Google Scholar
• Group KAW. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1-138
   Google Scholar
• Tian J, Barrantes F, Amoateng-Adjepong Y, Manthous CA. Rapid reversal of acute kidney injury and hospital outcomes: a retrospective cohort study. Am J Kidney Dis 2009;53(6):974-81
   PubMed Web of Science ®Google Scholar
• Vidt DG, Ridker PM, Monyak JT, et al. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). Clin Ther 2011;33(6):717-25
   PubMed Web of Science ®Google Scholar
• Bangalore S, Fayyad R, Hovingh GK, et al. Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials. Am J Cardiol 2014;113(12):2018-20
   PubMed Web of Science ®Google Scholar
• Sarma A, Cannon CP, de Lemos J, et al. The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome. J Am Heart Assoc 2014;3(3):e000784
   Web of Science ®Google Scholar
• Buhaescu I, Izzedine H. Mevalonate pathway: A review of clinical and therapeutical implications. Clin Biochem 2007;40(9–10):575-84
   PubMed Web of Science ®Google Scholar
• Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 2005;19(1):117-25
   PubMed Web of Science ®Google Scholar
• Sirtori CR. The pharmacology of statins. Pharmacol Res 2014;88:3-11
   PubMed Web of Science ®Google Scholar
• Sahoo S, Haraldsdottir HS, Fleming RM, Thiele I. Modeling the effects of commonly used drugs on human metabolism. FEBS J 2015;282(2):297-317
   PubMed Web of Science ®Google Scholar
• Prueksaritanont T, Ma B, Yu N. The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6. Br J Clin Pharmacol 2003;56(1):120-4
   PubMed Web of Science ®Google Scholar
• Hatanaka T. Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events. Clin Pharmacokinet 2000;39(6):397-412
   PubMed Web of Science ®Google Scholar
• Pasha MK, Muzeeb S, Basha SJ, et al. Analysis of five HMG-CoA reductase inhibitors–atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. Biomed Chromatogr 2006;20(3):282-93
   PubMed Web of Science ®Google Scholar
• Scott LJ, Curran MP, Figgitt DP. Rosuvastatin: a review of its use in the management of dyslipidemia. Am J Cardiovasc Drugs 2004;4(2):117-38
   PubMedGoogle Scholar
• Martin PD, Warwick MJ, Dane AL, et al. Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers. Clin Ther 2003;25(11):2822-35
   PubMed Web of Science ®Google Scholar
• Ii M, Losordo DW. Statins and the endothelium. Vasc Pharmacol 2007;46(1):1-9
   PubMed Web of Science ®Google Scholar
• Wang C-Y, Liu P-Y, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 2008;14(1):37-44
   PubMed Web of Science ®Google Scholar
• O’Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997;95(5):1126-31
   PubMed Web of Science ®Google Scholar
• Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet 1996;348(9034):1079-82
   PubMed Web of Science ®Google Scholar
• Omori H, Nagashima H, Tsurumi Y, et al. Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br J Clin Pharmacol 2002;54(4):395-9
   PubMed Web of Science ®Google Scholar
• Liao JK, Laufs U. Pleiotropic Effects Of Statins. Annu Rev Pharmacol Toxicol 2005;45(1):89-118
   PubMed Web of Science ®Google Scholar
• Ergin B, Kapucu A, Demirci-Tansel C, Ince C. The renal microcirculation in sepsis. Nephrol Dial Transplant 2015;30(2):169-77
   PubMed Web of Science ®Google Scholar
• Mose FH, Larsen T, Jensen JM, et al. Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease. Br J Clin Pharmacol 2014;78(4):789-99
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Kimura J. Mechanism of statin-induced rhabdomyolysis. J Pharmacol Sci 2013;123(4):289-94
   PubMed Web of Science ®Google Scholar
• Violi F, Calvieri C, Ferro D, Pignatelli P. Statins as antithrombotic drugs. Circulation 2013;127(2):251-7
   PubMed Web of Science ®Google Scholar
• Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med 2007;357(8):797-805
   PubMed Web of Science ®Google Scholar
• Sabbatini M, Pisani A, Uccello F, et al. Atorvastatin improves the course of ischemic acute renal failure in aging rats. J Am Soc Nephrol 2004;15(4):901-9
   PubMed Web of Science ®Google Scholar
• Wu K, Lei W, Tian J, Li H. Atorvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in rats. BMC Nephrol 2014;15:14
   PubMed Web of Science ®Google Scholar
• Gueler F, Rong S, Park JK, et al. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 2002;13(9):2288-98
   PubMed Web of Science ®Google Scholar
• Welten GM, Chonchol M, Schouten O, et al. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome. Nephrol Dial Transplant 2008;23(12):3867-73
   PubMed Web of Science ®Google Scholar
• Schouten O, Kok NF, Boersma E, et al. Effects of statins on renal function after aortic cross clamping during major vascular surgery. Am J Cardiol 2006;97(9):1383-5
   PubMed Web of Science ®Google Scholar
• Sanders RD, Nicholson A, Lewis SR, et al. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev 2013;7:CD009971
   PubMedGoogle Scholar
• Pan SY, Wu VC, Huang TM, et al. Effect of preoperative statin therapy on postoperative acute kidney injury in patients undergoing major surgery: systemic review and meta-analysis. Nephrology (Carlton) 2014;19(12):750-63
   PubMed Web of Science ®Google Scholar
• Molnar AO, Coca SG, Devereaux PJ, et al. Statin use associates with a lower incidence of acute kidney injury after major elective surgery. J Am Soc Nephrol 2011;22(5):939-46
   PubMed Web of Science ®Google Scholar
• Gallagher S, Jones DA, Lovell MJ, et al. The impact of acute kidney injury on midterm outcomes after coronary artery bypass graft surgery: a matched propensity score analysis. J Thorac Cardiovasc Surg 2014;147(3):989-95
   PubMed Web of Science ®Google Scholar
• Sehgal V, Bajwa SJ, Sehgal R, et al. Predictors of acute kidney injury in geriatric patients undergoing total knee replacement surgery. Int J Endocrinol Metab 2014;12(3):e16713
   Google Scholar
• Mithani S, Kuskowski M, Slinin Y, et al. Dose-dependent effect of statins on the incidence of acute kidney injury after cardiac surgery. Ann Thorac Surg 2011;91(2):520-5
   PubMed Web of Science ®Google Scholar
• Billings Iv FT, Pretorius M, Siew ED, et al. Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. J Cardiothoracic Vasc Anesth 2010;24(6):913-20
   PubMed Web of Science ®Google Scholar
• Layton JB, Kshirsagar AV, Simpson RJJr, et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol 2013;111(6):823-8
   PubMed Web of Science ®Google Scholar
• Argalious M, Xu M, Sun Z, et al. Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery. Anesth Analg 2010;111(2):324-30
   PubMed Web of Science ®Google Scholar
• Brunelli SM, Waikar SS, Bateman BT, et al. Preoperative statin use and postoperative acute kidney injury. Am J Med 2012;125(12):1195-204e3
   PubMed Web of Science ®Google Scholar
• Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 1999;15(4):394-9. discussion 99-400
   PubMed Web of Science ®Google Scholar
• Almansob MA, Xu B, Zhou L, et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. Arterioscler Thromb Vasc Biol 2012;32(9):2304-13
   PubMed Web of Science ®Google Scholar
• Chello M, Goffredo C, Patti G, et al. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. Eur J Cardiothorac Surg 2005;28(6):805-10
   PubMed Web of Science ®Google Scholar
• Prowle JR, Calzavacca P, Licari E, et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton) 2012;17(3):215-24
   PubMed Web of Science ®Google Scholar
• Spadaccio C, Pollari F, Casacalenda A, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol 2010;55(1):30-8
   PubMed Web of Science ®Google Scholar
• Mannacio VA, Iorio D, De Amicis V, et al. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg 2008;136(6):1541-8
   PubMed Web of Science ®Google Scholar
• Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database Syst Rev 2015;3:CD010480
   PubMedGoogle Scholar
• Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008;12(2):R47
   PubMed Web of Science ®Google Scholar
• Vincent JL, Bota DP, De Backer D. Epidemiology and outcome in renal failure. Int J Artif Organs 2004;27(12):1013-18
   PubMed Web of Science ®Google Scholar
• Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006;34(2):344-53
   PubMed Web of Science ®Google Scholar
• Ostermann M, Chang R. Correlation between the AKI classification and outcome. Crit Care 2008;12(6):R144
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee YS, Choi HM, et al. Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med 2012;40(11):2997-3006
   PubMed Web of Science ®Google Scholar
• Keir I, Kellum JA. Acute kidney injury in severe sepsis: Pathophysiology, diagnosis, and treatment recommendations. J Vet Emerg Crit Care (San Antonio) 2015;25(2):200-9
   PubMed Web of Science ®Google Scholar
• Benes J, Chvojka J, Sykora R, et al. Searching for mechanisms that matter in early septic acute kidney injury: an experimental study. Crit Care 2011;15(5):R256
   PubMed Web of Science ®Google Scholar
• Tleyjeh IM, Kashour T, Hakim FA, et al. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med 2009;169(18):1658-67
   PubMed Web of Science ®Google Scholar
• Kruger P, Fitzsimmons K, Cook D, et al. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 2006;32(1):75-9
   PubMed Web of Science ®Google Scholar
• Nseir W, Mograbi J, Abu-Elheja O, et al. The impact of prior long-term versus short-term statin use on the mortality of bacteraemic patients. Infection 2012;40(1):41-8
   PubMed Web of Science ®Google Scholar
• Zechmeister C, Hurren J, McNorton K. Continuation of statin therapy and vasopressor use in septic shock. Ann Pharmacother 2015;49(7):790-5
   PubMed Web of Science ®Google Scholar
• Leung S, Pokharel R, Gong MN. Statins and outcomes in patients with bloodstream infection: a propensity-matched analysis. Crit Care Med 2012;40(4):1064-71
   PubMed Web of Science ®Google Scholar
• Wan YD, Sun TW, Kan QC, et al. Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies. Crit Care 2014;18(2):R71
   PubMed Web of Science ®Google Scholar
• Patel JM, Snaith C, Thickett DR, et al. Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial). Crit Care 2012;16(6):R231
   PubMed Web of Science ®Google Scholar
• Papazian L, Roch A, Charles PE, et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA 2013;310(16):1692-700
   PubMed Web of Science ®Google Scholar
• Kruger P, Bailey M, Bellomo R, et al. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis. Am J Respir Crit Care Med 2013;187(7):743-50
   PubMed Web of Science ®Google Scholar
• East C, Alivizatos PA, Grundy SM, et al. Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation. N Engl J Med 1988;318(1):47-8
   PubMed Web of Science ®Google Scholar
• Dreier JP, Endres M. Statin-associated rhabdomyolysis triggered by grapefruit consumption. Neurology 2004;62(4):670
   PubMed Web of Science ®Google Scholar
• Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 2004;109(23 Suppl 1):III50-7
   PubMedGoogle Scholar
• Ganga HV, Slim HB, Thompson PD. A systematic review of statin-induced muscle problems in clinical trials. Am Heart J 2014;168(1):6-15
   PubMed Web of Science ®Google Scholar
• Desai CS, Martin SS, Blumenthal RS. Non-cardiovascular effects associated with statins. BMJ 2014;349:g3743
   PubMed Web of Science ®Google Scholar
• Rodriguez E, Soler MJ, Rap O, et al. Risk factors for acute kidney injury in severe rhabdomyolysis. PLoS One 2013;8(12):e82992
   PubMed Web of Science ®Google Scholar
• McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008;51(15):1419-28
   PubMed Web of Science ®Google Scholar
• Ball T, McCullough PA. Statins for the prevention of contrast-induced acute kidney injury. Nephron Clin Pract 2014;127(1-4):165-71
   PubMed Web of Science ®Google Scholar
• Gandhi S, Mosleh W, Abdel-Qadir H, Farkouh ME. Statins and contrast-induced acute kidney injury with coronary angiography. Am J Med 2014;127(10):987-1000
   PubMed Web of Science ®Google Scholar
• Giacoppo D, Capodanno D, Capranzano P, et al. Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization. Am J Cardiol 2014;114(4):541-8
   PubMed Web of Science ®Google Scholar
• Marenzi G, Cosentino N, Werba JP, et al. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes. Int J Cardiol 2015;183:47-53
   PubMed Web of Science ®Google Scholar
• Takagi H, Umemoto T. A meta-analysis of randomized trials for effects of periprocedural atorvastatin on contrast-induced nephropathy. Int J Cardiol 2011;153(3):323-5
   PubMed Web of Science ®Google Scholar
• Kostapanos M, Milionis H, Elisaf M. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia. Am J Cardiovasc Drugs 2010;10(1):11-28
   PubMed Web of Science ®Google Scholar
• Savarese G, Musella F, Volpe M, et al. Effects of atorvastatin and rosuvastatin on renal function: A meta-analysis. Int J Cardiol 2013;167(6):2482-9
   PubMed Web of Science ®Google Scholar
• Nicholls SJ, Ballantyne CM, Barter PJ, et al. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med 2011;365(22):2078-87
   PubMed Web of Science ®Google Scholar
• Geng Q, Ren J, Song J, et al. Meta-analysis of the effect of statins on renal function. Am J Cardiol 2014;114(4):562-70
   PubMed Web of Science ®Google Scholar